OPKO Health, Inc. , a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories, a clinical laboratory that offers laboratory testing services.
Surged higher Tuesday after the medical testing group's BioReference Labs division won a coronavirus screening contract with the National Football League.
- MCap - 3.49B | Debt/Eq- 0.18 |
- Price action has been positive for the last couple of weeks.
- Nice rounding bottom formation - classic text bookcase. Stock triplled in last one year.
- Entry around - $5.00
- SL - $4.00 ( WCB)
- around $6.5 and $7.5
Disc: Invested ( Tracking position, Trade @ own RISK. Education purpose only. Risk Management is the key.